About Company
Suzhou Sitan Wei biotechnology limited liability company in May 2007 incorporatedin the newly built a world-class hardware and software facilities in Suzhou Industrial Park BioBay (Suzhou-bioBAY); is a biomedical theory oriented, recombinant gene , cell culture and protein engineering technology as the basis, to the original genetic engineering of global proprietary monoclonal antibody research and development of new drugs of modern biotechnology
Suzhou Sitan Wei biotechnology limited liability company in May 2007 incorporatedin the newly built a world-class hardware and software facilities in Suzhou Industrial Park BioBay (Suzhou-bioBAY); is a biomedical theory oriented, recombinant gene , cell culture and protein engineering technology as the basis, to the original genetic engineering of global proprietary monoclonal antibody research and development of new drugs of modern biotechnology companies.
Sitan Wei company has access to China - Singapore Suzhou Industrial Park Ventures Co., Ltd. (referred to as the new venture CSVC) and Suzhou Tong Xiang Venture Capital Venture Capital in 2008 by the Suzhou Municipal Science and Technology Bureau issued a "domestic R & D institutions." title. Several major companies were awarded the founder of Cornell University, USA (Cornell University) School of Medicine, School of Medicine, Science and doctorate in molecular tumor immunology University of New York (New York University), and bear the national five "significant Drug Discovery" science and technology major projects and other research topics.
